ZA881777B - 6-oxoprostaglandin-e derivatives.method for their manufacture and their use as pharmaceuticals - Google Patents
6-oxoprostaglandin-e derivatives.method for their manufacture and their use as pharmaceuticalsInfo
- Publication number
- ZA881777B ZA881777B ZA881777A ZA881777A ZA881777B ZA 881777 B ZA881777 B ZA 881777B ZA 881777 A ZA881777 A ZA 881777A ZA 881777 A ZA881777 A ZA 881777A ZA 881777 B ZA881777 B ZA 881777B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- pct
- cycloalkyl
- alkyl
- free
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 3
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 3
- 229920000858 Cyclodextrin Polymers 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 abstract 1
- ROUDCKODIMKLNO-CTBSXBMHSA-N 6-oxoprostaglandin E1 Chemical class CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CC(=O)CCCCC(O)=O ROUDCKODIMKLNO-CTBSXBMHSA-N 0.000 abstract 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 abstract 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 abstract 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- -1 hydroxymethylene group Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873708537 DE3708537A1 (de) | 1987-03-13 | 1987-03-13 | 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA881777B true ZA881777B (en) | 1988-09-09 |
Family
ID=6323216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA881777A ZA881777B (en) | 1987-03-13 | 1988-03-11 | 6-oxoprostaglandin-e derivatives.method for their manufacture and their use as pharmaceuticals |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5023273A (xx) |
| EP (1) | EP0284547B1 (xx) |
| JP (1) | JPH01502750A (xx) |
| AT (1) | ATE99677T1 (xx) |
| AU (1) | AU620543B2 (xx) |
| CA (1) | CA1326022C (xx) |
| DE (2) | DE3708537A1 (xx) |
| DK (1) | DK160871C (xx) |
| ES (1) | ES2061715T3 (xx) |
| FI (1) | FI90661C (xx) |
| HU (1) | HU206342B (xx) |
| IE (1) | IE62469B1 (xx) |
| IL (1) | IL85711A (xx) |
| NZ (1) | NZ223858A (xx) |
| WO (1) | WO1988007037A1 (xx) |
| ZA (1) | ZA881777B (xx) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990002728A3 (de) * | 1988-09-09 | 1990-07-26 | Schering Ag | 6-oxo-9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4010339A1 (de) * | 1990-03-29 | 1991-10-02 | Schering Ag | Neues verfahren zur synthese von propargylalkoholen und dessen anwendung zur herstellung von prostaglandinvorstufen |
| DE19828881A1 (de) * | 1998-06-22 | 1999-12-23 | Schering Ag | Oxidationsinhibitor bei Prostan-Derivaten |
| JP6705974B2 (ja) * | 2017-11-08 | 2020-06-03 | Ａｇｃ株式会社 | 新規なプロスタグランジン誘導体を有効成分として含有する医薬 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU511711B2 (en) * | 1976-12-30 | 1980-09-04 | Upjohn Company, The | 6-Oxo and 5, 6-Dihalo prostaglandin analogues |
| US4205178A (en) * | 1976-12-30 | 1980-05-27 | The Upjohn Company | 6-Keto prostaglandin E-type compounds |
| DE2729960A1 (de) * | 1977-06-30 | 1979-01-18 | Schering Ag | Neue acetylenprostaglandine und verfahren zu ihrer herstellung |
| JPS6022710B2 (ja) * | 1977-09-16 | 1985-06-03 | 小野薬品工業株式会社 | プロスタグランジン類似化合物 |
| DE2907118A1 (de) * | 1979-02-20 | 1980-09-04 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
| DE2913856A1 (de) * | 1979-04-06 | 1980-10-23 | Hoechst Ag | Neue prostaglandinderivate in der 6-keto-pge tief 1 -reihe |
| ZA805820B (en) * | 1979-11-15 | 1981-09-30 | Upjohn Co | Prostacyclin analogues |
| DE3125271A1 (de) * | 1981-06-24 | 1983-01-13 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | (delta)(pfeil hoch)8(pfeil hoch),(pfeil hoch)9(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4403100A (en) * | 1981-10-30 | 1983-09-06 | The Upjohn Company | (11R)-11-Deoxy-11-alkyl-6-oxo-prostaglandins |
| JPS5973522A (ja) * | 1982-10-20 | 1984-04-25 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患治療剤 |
| JPS58203911A (ja) * | 1982-05-25 | 1983-11-28 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤 |
| AU565905B2 (en) * | 1984-02-29 | 1987-10-01 | John Deks Australia Pty. Ltd. | Improvements relating to flashing for buildings |
| US4540993A (en) * | 1984-07-23 | 1985-09-10 | Sanders Associates, Inc. | Plotter pen |
| JPS62277352A (ja) * | 1986-01-30 | 1987-12-02 | Ono Pharmaceut Co Ltd | 新規な６−ケト−プロスタグランジンｅ１誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤 |
-
1987
- 1987-03-13 DE DE19873708537 patent/DE3708537A1/de not_active Ceased
-
1988
- 1988-03-11 HU HU881863A patent/HU206342B/hu not_active IP Right Cessation
- 1988-03-11 WO PCT/DE1988/000151 patent/WO1988007037A1/de active IP Right Grant
- 1988-03-11 EP EP88730060A patent/EP0284547B1/de not_active Expired - Lifetime
- 1988-03-11 ZA ZA881777A patent/ZA881777B/xx unknown
- 1988-03-11 CA CA000561283A patent/CA1326022C/en not_active Expired - Fee Related
- 1988-03-11 US US07/276,502 patent/US5023273A/en not_active Expired - Fee Related
- 1988-03-11 AT AT88730060T patent/ATE99677T1/de active
- 1988-03-11 ES ES88730060T patent/ES2061715T3/es not_active Expired - Lifetime
- 1988-03-11 NZ NZ223858A patent/NZ223858A/en unknown
- 1988-03-11 AU AU14237/88A patent/AU620543B2/en not_active Ceased
- 1988-03-11 DE DE88730060T patent/DE3886798D1/de not_active Expired - Fee Related
- 1988-03-11 JP JP63502393A patent/JPH01502750A/ja active Pending
- 1988-03-11 IL IL85711A patent/IL85711A/xx not_active IP Right Cessation
- 1988-03-14 IE IE73788A patent/IE62469B1/en not_active IP Right Cessation
- 1988-11-11 FI FI885219A patent/FI90661C/fi not_active IP Right Cessation
- 1988-11-11 DK DK632588A patent/DK160871C/da not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990002728A3 (de) * | 1988-09-09 | 1990-07-26 | Schering Ag | 6-oxo-9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Also Published As
| Publication number | Publication date |
|---|---|
| IL85711A0 (en) | 1988-08-31 |
| DK632588A (da) | 1988-11-11 |
| IE880737L (en) | 1988-09-13 |
| FI90661C (fi) | 1994-03-10 |
| FI885219A (fi) | 1988-11-11 |
| DE3886798D1 (de) | 1994-02-17 |
| HU206342B (en) | 1992-10-28 |
| EP0284547A1 (de) | 1988-09-28 |
| WO1988007037A1 (fr) | 1988-09-22 |
| AU620543B2 (en) | 1992-02-20 |
| HUT49118A (en) | 1989-08-28 |
| ATE99677T1 (de) | 1994-01-15 |
| JPH01502750A (ja) | 1989-09-21 |
| FI90661B (fi) | 1993-11-30 |
| NZ223858A (en) | 1990-11-27 |
| US5023273A (en) | 1991-06-11 |
| DK632588D0 (da) | 1988-11-11 |
| AU1423788A (en) | 1988-10-10 |
| DE3708537A1 (de) | 1988-09-22 |
| FI885219A0 (fi) | 1988-11-11 |
| IE62469B1 (en) | 1995-02-08 |
| ES2061715T3 (es) | 1994-12-16 |
| CA1326022C (en) | 1994-01-11 |
| DK160871C (da) | 1991-10-14 |
| DK160871B (da) | 1991-04-29 |
| EP0284547B1 (de) | 1994-01-05 |
| IL85711A (en) | 1993-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0239445A3 (en) | 1,2,5,6-tetrahydropyridine-3-carboxaldehyde oxime derivatives, process for their preparation, compositions containing them and their use as medicines | |
| ZA881777B (en) | 6-oxoprostaglandin-e derivatives.method for their manufacture and their use as pharmaceuticals | |
| ATE73445T1 (de) | 1,2,5,6-tetrahydropyridinoxim-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
| ZA886131B (en) | Derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde,the process for their preparation,their use as medicaments and the compositions containing them | |
| IL103229A0 (en) | Imidazolylmethyl-pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| ES515744A0 (es) | "procedimiento de preparacion de derivados de amino-2-tetrahidro-1,2,3,4-naftaleno". | |
| SE8205868D0 (sv) | A titre de medicaments, certains derives de lacide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
| DE3160968D1 (en) | Cardenolide-bis-digitoxoside derivatives, process for their preparation and their utilization as medicines |